Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Thomas J, Quinn"'
Autor:
Vincent P. Grzywacz, Thomas J. Quinn, Muayad F. Almahariq, Zaid A. Siddiqui, Sang W. Kim, Thomas M. Guerrero, Craig W. Stevens, Inga S. Grills
Publikováno v:
Cancer Treatment and Research Communications, Vol 32, Iss , Pp 100571- (2022)
Purpose: Debate exists regarding the optimal management for patients with stage III non-small-cell lung cancer (NSCLC). Recent inclusion of chemotherapeutic data in the Surveillance, Epidemiology, and End Results (SEER) database has made it possible
Externí odkaz:
https://doaj.org/article/337a375d711e4ed5ae241a3c1174cb83
Publikováno v:
Health Science Reports, Vol 4, Iss 2, Pp n/a-n/a (2021)
Abstract Background In this retrospective surveillance, epidemiology, and end results (SEER) registry analysis, we investigated the role of chemotherapy (CT) in the treatment of olfactory neuroblastoma (ON), an exceedingly rare sino‐nasal tumor typ
Externí odkaz:
https://doaj.org/article/5ee64ba148234a529c7443e180060133
Autor:
Benjamin D. Willen, Thomas J. Quinn, Muayad F. Almahariq, Peter Y. Chen, M. Saada Jawad, Gregory S. Gustafson, Eva Leung, Michelle Ka Yan Wu, Joshua T. Dilworth
Publikováno v:
Practical Radiation Oncology. 12:e501-e511
Adoption of hypofractionated whole breast irradiation (HWBI) for patients with early-stage, biologically high-risk breast cancer remains relatively low. We compared clinical outcomes of conventionally fractionated whole breast irradiation (CWBI) vers
Autor:
Jacob S Parzen, Thomas Guerrero, Andrew B. Thompson, Thomas J. Quinn, Craig W. Stevens, K.C. Lee, Zaid A. Siddiqui, Inga S. Grills, Muayad F. Almahariq
Publikováno v:
Radiotherapy and Oncology. 160:25-31
Background Multiple studies have suggested that patients with early-stage SCC of the lung treated with SBRT are more susceptible to local failure compared to other NSCLC histologies. It is unknown if higher BED leads to improved outcomes in this pati
Autor:
Girish B. Nair, Sarah Westergaard, Scott Emerson, Craig W. Stevens, Edward M. Castillo, Nicholas Myziuk, Thomas Guerrero, Yevgeniy Vinogradskiy, Richard Castillo, Sayf Al-Katib, Thomas J. Quinn, Danielle Turner-Lawrence
Publikováno v:
Medical Physics
PURPOSE Computed tomography (CT)-derived ventilation methods compute respiratory induced volume changes as a surrogate for pulmonary ventilation. Currently, there are no known methods to derive perfusion information from noncontrast CT. We introduce
Autor:
Joshua T. Dilworth, Peter Y. Chen, Thomas J. Quinn, Maha S. Jawad, Andrew B. Thompson, G.S. Gustafson, Aleksander Vayntraub
Publikováno v:
Medical Dosimetry. 46:57-64
Dose to the left anterior descending artery (LAD) may be significant in patients receiving left-sided irradiation for breast cancer. We investigated if prospective contouring and avoidance of the LAD during treatment planning were associated with low
Autor:
Pravin Kesarwani, Shiva Kant, Muayad F. Almahariq, Thomas J. Quinn, Prakash Chinnaiyan, C. Ryan Miller
Publikováno v:
In Vivo
Aim To use inhibition of colony-stimulating factor-1 receptor (CSF-1R) to target tumor-associated macrophages (TAMs) and improve the efficacy of radiotherapy in glioblastoma (GBM). Materials and methods The CSF-1R inhibitor BLZ-945 was used to examin
Autor:
Thomas J. Quinn, Craig W. Stevens, Andrew B. Thompson, Nikhil P. Mankuzhy, Thomas Guerrero, Zaid A. Siddiqui, K.C. Lee, Inga S. Grills, Muayad F. Almahariq
Publikováno v:
Clinical Lung Cancer. 22:e5-e17
Background The role for postoperative radiation therapy (PORT) for patients with non–small-cell lung cancer (NSCLC) with mediastinal lymph node (LN) involvement (pN2 disease) is controversial. We compared surgery alone with PORT among patients with
Autor:
Thomas J. Quinn, Peyman Kabolizadeh
Publikováno v:
J Gastrointest Oncol
BACKGROUND: There is an alarming rise in incidence among young patients with rectal cancer. The National Cancer Database (NCDB) and Surveillance, Epidemiology, and End Results Analysis (SEER) databases may help identify population level disparities i
Autor:
Thomas J. Quinn, Inga S. Grills, Andrew B. Thompson, Zaid A. Siddiqui, Craig W. Stevens, Muayad F. Almahariq
Publikováno v:
Lung Cancer. 146:120-126
Introduction Malignant pleural mesothelioma (MPM) is a devastating disease with poor survival outcomes for most patients. Optimizing therapeutic approaches is thus vital, but has been hampered by a dearth of randomized trials to guide decision making